Home/Investors/GL Ventures

GL Ventures

Biotech Investor · 10 portfolio companies

Portfolio

10

Focus Areas

10

Top Stage

preclinical

Investment Focus

Oncology Genetic Disorders Genetics & Genomics Immunology Gastrointestinal Diseases Central Nervous System Diseases Cardiovascular Diseases CNS Infectious Disease Genetics

Portfolio Companies

Company	Stage	Valuation	Focus
CureGene	preclinical	—	Oncology, Genetic Disorders
Escugen	preclinical	—	Genetic Disorders, Oncology
Codone Biotechnology	preclinical	—	Genetics & Genomics
Antengene	commercial	—	Oncology, Immunology
Ractigen Therapeutics	preclinical	—	Genetics & Genomics, Oncology
Triastek	phase-2	—	Gastrointestinal Diseases, Central Nervous System Diseases
Delova Biotech	phase-1	—	Oncology
Taron Solutions	platform	—	CNS, Infectious Disease
Westlake Genetech	commercial	—	Genetics, Oncology
Kanglin Biotechnology	phase-1	—	Oncology, Immunology

Frequent Co-Investors

Sinovation Ventures3 shared Sequoia Capital China2 shared 3H Health Investment2 shared Angel investors1 shared Qiming Venture Partners1 shared Boyu Capital1 shared China Merchants Capital1 shared TF Capital1 shared